glp 1 and eyes GLP-1 Drugs Diabetic Eye Disease: Ozempic, Semaglutide, and Retinopathy Risk Focus on GLP-1 drugs &

Adults with obesity who reported more intense tastes while receiving semaglutide or tirzepatide had a higher likelihood for increased satiety and decreased appetite and food cravings, according to a presenter

Diabetes and obesity drugs show promise in treating and preventing all substance use disorders

A comprehensive program of nutritional and lifestyle counseling is critical to maximize overall efficacy and improve cost-effectiveness of GLP-1s for obesity.

Today, people are actively searching fordoctor-guided, science-backed solutionsthey can trust

Therapy helps with food noise, body image concerns, and support around weight gain fears.

Detox+: Binder to reduce bloating and gas*